Archives
-
Serine/Glycine-Free Diet and PD-L1 Lactylation
2026-09-09
A 2024 Cell Metabolism study shows that removing serine and glycine from the diet can inhibit colorectal cancer growth and increase cytotoxic T-cell accumulation, while also triggering PD-L1 lactylation that delays lysosomal degradation and supports immune evasion. Its preclinical findings and single-arm phase I study support dietary metabolic intervention as a promising but investigational partner for checkpoint immunotherapy.
-
Pravastatin Sodium in Hepatocyte Transporter Studies
2026-09-08
Pravastatin sodium is more than an HMG-CoA reductase inhibitor: its cellular activity must be interpreted alongside hepatocyte uptake, viability, and transporter assays. This article connects cholesterol biosynthesis inhibition with the translational lessons of açaí hepatocyte research.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-09-08
A 2026 FASEB Journal study developed chemically modified p21 mRNA in lipid nanoparticles for localized intravesical treatment of bladder cancer. The formulation restored nuclear p21, disrupted tumor-cell proliferation, and suppressed orthotopic tumor growth while producing predominantly bladder-localized expression in mice.
-
Trolox for Redox-Aware Organoid Assays
2026-09-07
Trolox can do more than serve as an antioxidant benchmark: it can help determine whether pancreatic organoid phenotypes are driven by oxidative injury or altered cell-state biology. This article translates recent pancreatic ductal organoid findings into a rigorous, redox-aware assay framework.
-
TBST (Tris-Buffered Saline and Tween 20) Guide
2026-09-07
TBST provides a buffered, detergent-containing environment for antibody dilution, blocking-solution preparation, and washing in Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. It should be used only where the assay tolerates Tween 20, and it should not be treated as a complete blocking reagent or as a universal substitute for detergent-free buffers.
-
Cholesterol in mRNA-LNP Workflows
2026-09-05
Cholesterol is the principal sterol for tuning lipid nanoparticle structure, membrane behavior, and localized mRNA delivery workflows. This practical guide connects cholesterol formulation, membrane fluidity assay design, and the bladder cancer p21 mRNA-LNP study while emphasizing controls, characterization, and troubleshooting.
-
Hydroxychloroquine Sulfate: Protocol Guide
2026-09-04
Hydroxychloroquine Sulfate provides an aqueous research reagent for controlled studies of autophagy pathway modulation and TLR7/9-mediated immune signaling. It is suited to short-term cell and animal workflows, but should not be selected for protocols requiring DMSO or ethanol solubility or long-term storage of prepared solutions.
-
Rosiglitazone (Brl-49653) in Metabolic Research
2026-09-04
A translational perspective on how Rosiglitazone connects PPARγ biology, adipose thermogenesis, insulin sensitivity, and disease-model validation, with practical guidance for integrating pharmacology with SETD7-centered research.
-
Nr4a1–C3 Axis in TMJ-Linked Depression
2026-09-03
This study identifies a hippocampal pathway linking temporomandibular joint inflammation to depression-like behaviors in mice: loss of microglial Nr4a1 activates phagocytic microglia, while increased neuronal C3 deposition is associated with excessive synaptic pruning. The work combines pharmacological inhibition, gene manipulation, immunofluorescence, and behavioral analysis to define microglial Nr4a1 and neuronal C3 as mechanistic candidates rather than merely correlational markers.
-
Midecamycin for Reproducible Antibacterial Assays
2026-09-03
Learn how Midecamycin (SKU BA1041) can help laboratories distinguish bacterial inhibition from mammalian-cell viability effects. This scenario-based guide covers mechanism, controls, solvent handling, concentration selection, data interpretation, and practical product evaluation.
-
HyperScribe T7 High Yield RNA Synthesis Kit Plus
2026-09-02
Build scalable T7 transcription workflows for rescue mRNA, labeled probes, RNAi, and biochemical assays. The HyperScribe T7 High Yield RNA Synthesis Kit Plus combines high-yield synthesis with practical options for modified RNA and downstream purification.
-
GLP Enhances mRNA-LNP Delivery and Translation
2026-09-02
A 2026 Pharmaceutics study identified Ganoderma lucidum polysaccharide (GLP) as an adjuvant that improved mRNA-LNP expression while reducing oxidative stress. Its modular formulation strategy increased protein output in cell and animal experiments, offering a complementary alternative to redesigning lipid components.
-
Metoprolol Research Workflows and PK Optimization
2026-09-01
Build reproducible cardiovascular assays with Metoprolol while extending the same pharmacologic perturbation strategy to inflammation, cancer, and angiogenesis models. A disease-state-aware pharmacokinetic workflow, informed by a recent UHPLC-MS/MS study, helps distinguish receptor biology from exposure, transport, and handling artifacts.
-
5-Azacytidine Reprograms Dormant Cancer Cells
2026-09-01
Singh et al. show that sequential 5-Azacytidine and retinoic-acid-receptor agonist treatment can reprogram disseminated cancer cells into a stable dormant state rather than simply eliminating them. The study links metastatic suppression to restoration of TGF-β–SMAD4 signaling and identifies SMAD4 loss as a mechanism of resistance, offering a framework for studying therapeutic control of residual disease.
-
Cholesterol for mRNA-LNP Research
2026-08-31
Cholesterol is the principal sterol for membrane engineering, liposome development, and mRNA–lipid nanoparticle workflows. This guide translates localized p21 mRNA delivery findings into practical formulation, membrane fluidity assay, storage, and troubleshooting strategies using a defined cholesterol research compound.